Publications

5600 Results

A phase II basket trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic neoplasia

Authors
S Patel;M Othus;Y Chae;M Dennis;S Gordon;D Mutch;W Samlowski;W Robinson;E Sharon;C Ryan;G Lopez;M Plets;C Blanke;R Kurzrock
Journal / Conference
Clinical Cancer Research Jan 5;30(1):33-38
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID37882676
PMC
PMC10842092
Study Number(s)
S1609

Predicting clinical outcomes in the S1314-COXEN Trial using a Multimodal Deep Learning Model Integrating Histopathology, Cell Types, and Gene Expression

Authors
B Faltas;Z Bai;M Osman;M Brendel;C Tangen;T Flaig;M Plets;MS Lucia;D Theodorescu;D Gustafson;S Daneshmand;J Meeks;W Choi;C Dinney;O Elemento;S Lerner;D McConkey;F Wang
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), oral
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S1314

PAPMET2 A Phase II Randomized Trial of Cabozantinib with or without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma (PRCC): SWOG S2200)

Authors
B Maughan;M Plets;Y Ged;C Tangen;U Vaishampayan;S Lerner;S Lerner;I Thompson
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), TIPS, poster
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S2200

SWOG S2210: A PHASE II STUDY OF NEOADJUVANT CARBOPLATIN FOR LOCALIZED, HIGH RISK PROSTATE CANCER WITH GERMLINE BRCA1/2 MUTATIONS

Authors
H Cheng;S Callis;D Lin;E Yu;T Dorff;A Kase;C Tangen;D Petrylak;S Lerner
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), TIPS, poster
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S2210

AMBASSADOR Alliance A031501: Phase III Randomized Adjuvant Study of Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma (MIBC) vs Observation

Authors
A Apolo;K Ballman;G Sonpavde;S Berg;W Kim;R Parikh;M Teo;R Sweis;D Geynisman;P Grivas;E Levine;Z Reichert;J Kim;M Bilen;Y Wen;O Hahn;S Halabi;G Perez;M Morris;J Rosenberg
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), oral; J Clin Oncol 42, 2024 (suppl 4; abstr LBA531)
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/A031501

Bone pain as a prognostic marker for survival for men with metastatic hormone-sensitive prostate cancer (mHSPC): Patient level analysis of SWOG 1216 trial

Authors
G Gebrael;M Plets;Y Jo;U Swami;C Chehade;A Narang;S Gupta;N Sayegh;C Tangen;M Hussain;T Dorff;P Lara;S Lerner;I Thompson;N Agarwal
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), poster
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S1216

Urinary comprehensive genomic profile correlates with risk of recurrence of BCG-unresponsive non-muscle invasive bladder cancer treated with atezolizumab in SWOG S1605

Authors
M St-Laurent;M Plets;P Black;P Singh;D McConkey;MS Lucia;V Koshkin;K Stratton;T Bivalacqua;W Kassouf;S Porten;R Bangs;C Tangen;I Thompson;J Meeks;V Caruso;K Philllips;V Bicocca;T Levin;S Lerner
Journal / Conference
ASCO GU Symposium (JAN 25-27, 2024, San Francisco, CA), oral
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S1605

A phase 1 study of triple targeted therapy with BRAF, MEK and AKT inhibitors for patients with BRAF mutated cancers

Authors
AP Algazi;J Moon;C Lao;B Chmielowski;K Kendra;K Lewis;R Gonzalez;K Kim;JE Godwin;B Curti;M Latkovic-Taber;S Lomeli;B Gufford;P Scumpia;R Lo;M Othus;A Ribas
Journal / Conference
Cancer May 15;130(10):1784-1796
Year
2024
Research Committee(s)
Melanoma
PMID
PMID38261444
Study Number(s)
S1221

Multi-omics profiling reveals molecular and immune features associated with benefit from immunotherapy for advanced squamous cell lung cancer patients from the phase III SWOG Lung-MAP S1400I trial

Authors
E Parra;D Duose;J Zhang;M Redman;R Lazcano Segura;M Marques-Puibelli;C Fernandez;B Zhang;J Lindsay;R Moravec;K Kannan;R Luthra;G Al-atrash;R Herbst;I Wistuba;S Gettinger;L Bazhenova;J Lee;J Zhang;C Haymaker;G Manyam;J Zhang;X Song;F Rojas;L Taing;A Jhaveri;J Geisberg;J Altreuter;F Michor;D Van Nostrand;J Provencher;J Yu;E Cerami;H Huang;H Xie;M Patel;K Nie;J Harris;K Argueta;R Biswas;S Kim-Schulze;K Kelly;S Gnjatic
Journal / Conference
Clinical Cancer Research Apr 15;30(8):1655-1668
Year
2024
Research Committee(s)
Lung
PMID
PMID38277235
PMC
PMC11016892
Study Number(s)
S1400I

Clinical Evaluation of Complete Remission (CR) with Partial Hematologic Recovery (CRh) in Acute Myeloid Leukemia: A Report of 7,235 Patients from Seven Cohorts Running head: Survival following CRh in AML

Authors
J Appelbaum;A Wei;S Mandrekar;I Tiong;C Chua;T Teh;C Fong;S Ting;D Weber;A Benner;H Hill;M Saadati;J Yin;R Stone;G Garcia-Manero;H Erba;G Yy;G Marcucci;R Larson;A Thomas;S Freeman;N Marquez Almuina;K Dohner;I Thomas;N Russel;H Dohner;M Othus;E Estey;R Walter
Journal / Conference
Leukemia Feb;38(2):389-392
Year
2024
Research Committee(s)
Leukemia
PMID
PMID38263433